The endothelin ETA receptor antagonist, BQ-123, normalizes the response of SHR aorta to Ca2+ channel activator
- 3 February 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 252 (2), R3-R4
- https://doi.org/10.1016/0014-2999(94)90603-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive modelLife Sciences, 1993
- Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.Hypertension, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Effect of Nitric Oxide on Membrane Potential and Contraction of Rat AortaJournal of Cardiovascular Pharmacology, 1992
- Endothelium-derived contracting factors.Hypertension, 1992
- Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats.Circulation Research, 1991